Cargando…
Palliative chemotherapy outcomes in patients with ECOG-PS higher than 1
PURPOSE: Although patients with incurable disease and Eastern Cooperative Oncology Group performance status (ECOG-PS ≥ 2) are underrepresented in clinical trials, they are frequently offered palliative chemotherapy (pCT) in daily clinical practice in order to improve symptoms and quality of life. In...
Autores principales: | Caires-Lima, Rafael, Cayres, Karolina, Protásio, Bruno, Caires, Inacelli, Andrade, Júlia, Rocha, Lucila, Takahashi, Tiago Kenji, Hoff, Paulo M, de Castro, Gilberto, Mak, Milena Perez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931814/ https://www.ncbi.nlm.nih.gov/pubmed/29743951 http://dx.doi.org/10.3332/ecancer.2018.831 |
Ejemplares similares
-
Collagen content and C-X-C motif chemokine ligand 12 expression in neoplastic breast stroma
por: Ferreira, Cindy Juliane da Silva, et al.
Publicado: (2023) -
Immunotherapy in patients with non-small cell lung cancer with ECOG PS 2
por: Mojsak, Damian, et al.
Publicado: (2021) -
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100
por: Schneider, B P, et al.
Publicado: (2014) -
Predicting survival in metastatic non‐small cell lung cancer patients with poor ECOG‐PS: A single‐arm prospective study
por: Cunha, Mateus Trinconi, et al.
Publicado: (2022) -
Formal techniques for distributed objects, components, and systems: 38th IFIP WG 6. 1 international conference, FORTE 2018, held as part of the 13th international federated conference on distributed computing techniques, DisCoTec 2018, Madrid, Spain, June 18-21, 2018, proceedings
por: Baier, Christel, et al.
Publicado: (2018)